[Opinion] Should the 90% CI for GMR be required to encompass 1 [RSABE / ABEL]

posted by bebac_fan – US, 2018-03-29 18:57 (1893 d 20:10 ago) – Posting: # 18617
Views: 9,072

Dear John

❝ So basically he's questioning the validity of FDA's 20% window on BE then...

Actually, I am questioning the validity of FDA's Swr scaled 10% window on BE for NTID.

If a GMR of 1.1 is clinically relevant (i.e. a test should be sensitive for this), and the NTID with a Swr of .22 will pass by ABE, this is a failure IMO.


Complete thread:

UA Flag
 Admin contact
22,616 posts in 4,740 threads, 1,614 registered users;
18 visitors (0 registered, 18 guests [including 8 identified bots]).
Forum time: 15:08 CEST (Europe/Vienna)

Mediocrity is a fungus of the mind.    Reif Larsen

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz